Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jack A Roth

Showing results (121-130 of 352) with videos related to

Pageof 36
Sort By:
Scientific Reports|November 16, 2016
TUSC2(FUS1)-erlotinib Induced Vulnerabilities in Epidermal Growth Factor Receptor(EGFR) Wildtype Non-small Cell Lung Cancer(NSCLC) Targeted by the Repurposed Drug AuranofinCao Xiaobo, Mourad Majidi, Meng Feng, et al.
Oncotarget|January 4, 2018
TUSC2 downregulates PD-L1 expression in non-small cell lung cancer (NSCLC)Xiaobo Cao, Yang Zhao, Jing Wang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 9, 2010
Prognostic significance of RNA-dependent protein kinase on non-small cell lung cancer patientsAbujiang Pataer, Maria Gabriela Raso, Arlene M Correa, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 2, 2003
Increased uptake of liposomal-DNA complexes by lung metastases following intravenous administrationIsao Ito, Gopalan Began, Imran Mohiuddin, et al.
Annals of Surgical Oncology|December 25, 2012
Predictors for locoregional recurrence for clinical stage III-N2 non-small cell lung cancer with nodal downstaging after induction chemotherapy and surgeryArya Amini, Feiran Lou, Arlene M Correa, et al.
Molecular Cancer Therapeutics|October 17, 2013
IGFBP2/FAK pathway is causally associated with dasatinib resistance in non-small cell lung cancer cellsHaibo Lu, Li Wang, Wen Gao, et al.
Cancer Gene Therapy|December 4, 2004
Selective induction of cell cycle arrest and apoptosis in human prostate cancer cells through adenoviral transfer of the melanoma differentiation-associated -7 (mda-7)/interleukin-24 (IL-24) geneYuji Saito, Ryo Miyahara, Began Gopalan, et al.
Scientific Reports|July 14, 2015
Genetic variation in the TNF/TRAF2/ASK1/p38 kinase signaling pathway as markers for postoperative pulmonary complications in lung cancer patientsMichelle A T Hildebrandt, Jack A Roth, Ara A Vaporciyan, et al.
Scientific Reports|August 24, 2017
A miR-SNP biomarker linked to an increased lung cancer survival by miRNA-mediated down-regulation of FZD4 expression and Wnt signalingJing Lin, Roza Zandi, Ruping Shao, et al.
International Journal of Cancer|September 25, 2003
Aberrant methylation of the cyclin D2 promoter in primary small cell, nonsmall cell lung and breast cancersArvind Virmani, Asha Rathi, Shashank Heda, et al.
Pageof 36

Showing results (121-130 of 352) with videos related to

Sort By:
Pageof 36
Scientific Reports|November 16, 2016
TUSC2(FUS1)-erlotinib Induced Vulnerabilities in Epidermal Growth Factor Receptor(EGFR) Wildtype Non-small Cell Lung Cancer(NSCLC) Targeted by the Repurposed Drug AuranofinCao Xiaobo, Mourad Majidi, Meng Feng, et al.
Oncotarget|January 4, 2018
TUSC2 downregulates PD-L1 expression in non-small cell lung cancer (NSCLC)Xiaobo Cao, Yang Zhao, Jing Wang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 9, 2010
Prognostic significance of RNA-dependent protein kinase on non-small cell lung cancer patientsAbujiang Pataer, Maria Gabriela Raso, Arlene M Correa, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 2, 2003
Increased uptake of liposomal-DNA complexes by lung metastases following intravenous administrationIsao Ito, Gopalan Began, Imran Mohiuddin, et al.
Annals of Surgical Oncology|December 25, 2012
Predictors for locoregional recurrence for clinical stage III-N2 non-small cell lung cancer with nodal downstaging after induction chemotherapy and surgeryArya Amini, Feiran Lou, Arlene M Correa, et al.
Molecular Cancer Therapeutics|October 17, 2013
IGFBP2/FAK pathway is causally associated with dasatinib resistance in non-small cell lung cancer cellsHaibo Lu, Li Wang, Wen Gao, et al.
Cancer Gene Therapy|December 4, 2004
Selective induction of cell cycle arrest and apoptosis in human prostate cancer cells through adenoviral transfer of the melanoma differentiation-associated -7 (mda-7)/interleukin-24 (IL-24) geneYuji Saito, Ryo Miyahara, Began Gopalan, et al.
Scientific Reports|July 14, 2015
Genetic variation in the TNF/TRAF2/ASK1/p38 kinase signaling pathway as markers for postoperative pulmonary complications in lung cancer patientsMichelle A T Hildebrandt, Jack A Roth, Ara A Vaporciyan, et al.
Scientific Reports|August 24, 2017
A miR-SNP biomarker linked to an increased lung cancer survival by miRNA-mediated down-regulation of FZD4 expression and Wnt signalingJing Lin, Roza Zandi, Ruping Shao, et al.
International Journal of Cancer|September 25, 2003
Aberrant methylation of the cyclin D2 promoter in primary small cell, nonsmall cell lung and breast cancersArvind Virmani, Asha Rathi, Shashank Heda, et al.
Pageof 36